TMCnet News

Research and Markets: Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2014 Report
[March 04, 2014]

Research and Markets: Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2014 Report


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/p679w2/acute) has announced the addition of the "Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2014" report to their offering.

Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2014 provides data on the Acute Promyelocytic Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Promyelocytic Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Promyelocytic Leukemia.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, iddle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations



- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Key Topics Covered:

List of Tables

List of Figures

Introduction

Acute Promyelocytic Leukemia

Report Guidance

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Clinical Trials by G7 Countries: Proportion of Acute Promyelocytic Leukemia to Oncology Clinical Trials

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Unaccomplished Trials of Acute Promyelocytic Leukemia

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Acute Promyelocytic Leukemia Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profiles

Clinical Trial Overview of Top Companies

Five Key Clinical Profiles

Appendix

For more information visit http://www.researchandmarkets.com/research/p679w2/acute

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]